- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Despite forty years of global research efforts, no one has yet succeeded in curing HIV or even developing a protective vaccine. Ole Schmeltz Søgaard is doing his best to change this. He is a new professor of translational viral research at Aarhus University and Aarhus University Hospital.
2021.06.17 |
![[Translate to English:] Det nye professorat styrker Ole Schmeltz Søgaards muligheder for at sætte HIV-forskningen på dagsordenen. Bl.a. ved at udbygge nationale og internationale forskningssamarbejder og udarbejde større fondsansøgninger. Foto: Simon Byrial Fischel, AU Health.](https://newsroom.au.dk/typo3temp/_processed_/csm_Ole_Schmeltz_Soegaard__5__cd10b489c4.jpg "The new professorship gives Ole Schmeltz Søgaard an even better opportunity to put HIV research on the agenda. Among other things, by developing national and international research collaborations and preparing major funding applications. Photo: Simon Byrial Fischel, AU Health.")
The new professorship gives Ole Schmeltz Søgaard an even better opportunity to put HIV research on the agenda. Among other things, by developing national and international research collaborations and preparing major funding applications. Photo: Simon Byrial Fischel, AU Health.
Ole Schmeltz Søgaard has been appointed professor at the Department of Clinical Medicine, where he conducts research into how viral infections and the immune system interact with each other. Part of his work involves examining how HIV avoids the immune system and what is required to alter this balance, so that HIV goes from being a life-long chronic infection to being a disease that can be cured with short-term targeted treatment.
The newly-appointed professor is ambitious when it comes to finding a cure or developing a vaccine against HIV – not least now, where researchers in connection with SARS-CoV-2 have shown that it is possible to develop effective vaccines and treatments in less than a year.
Ole Schmeltz Søgaard is currently leading two international randomised trials which aim to strengthen the immune system's ability to control the HIV infection without the need for daily medicine. He is furthermore involved in different projects that examine the role played by specific components in the immune system in relation to controlling viral infections, including COVID-19.
Ole Schmeltz Søgaard's research helps to prevent and cure viral infections using, among other things, immunotherapy, vaccines and antibodies, and is particularly significant for patients living with chronic viral infections such as HIV.
Professor, MD & PhD Ole Schmeltz Søgaard
Aarhus University, Department of Clinical Medicine and
Aarhus University Hospital, Department of Infectious Diseases
Tel.: (+45) 78 45 28 42
Email: olesoega@rm.dk